Cholesterol level increases greater with indinavir than saquinavir

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 755卷 / 1期
关键词：
Cholesterol; Treatment Group; Protease Inhibitor; Cholesterol Level; Ritonavir;
D O I：
10.2165/00128415-199907550-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [11] Olanzapine causes greater increases in serum lipids than risperidone
    Tang, T
    Meltzer, HY
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 367 - 367
  • [12] Simultaneous HPLC assay for quantification of indinavir, nelfinavir, ritonavir, and saquinavir in human plasma
    Remmel, RP
    Kawle, SP
    Weller, D
    Fletcher, CV
    CLINICAL CHEMISTRY, 2000, 46 (01) : 73 - 81
  • [13] Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells
    Armbruster, C
    Vorbach, H
    Steindl, F
    El Menyawi, I
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) : 487 - 490
  • [14] Grapefruit juice increases the bioavailability of saquinavir
    Reactions Weekly, 1998, 697 (1) : 5 - 5
  • [15] Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma
    Sudhakaran, Sreeja
    Rayner, Craig R.
    Li, Jian
    Kong, David C. M.
    Gude, Neil M.
    Nation, Roger L.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 315 - 321
  • [16] Aspergillus fumigatus IgG level greater than 60 mg/L Increases Diagnostic Specificity of Allergic Bronchopulmonary Aspergillosis
    Khan, Sujoy
    Chowdhury, Sushmita R.
    Holding, Stephen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB95 - AB95
  • [17] Simultaneous determination of indinavir, ritonavir and saquinavir in plasma by high-performance liquid chromatography
    Hsieh, SM
    Yu, HY
    Chang, SC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (03) : 191 - 195
  • [18] Clinical use of a simultaneous HPLC assay for indinavir, saquinavir, ritonavir, and nelfinavir in children and adults
    Walson, PD
    Cox, S
    Utkin, I
    Gerber, N
    Crim, L
    Brady, M
    Koranyi, K
    THERAPEUTIC DRUG MONITORING, 2003, 25 (06) : 649 - 656
  • [19] Acute hepatitis in a patient treated with saquinavir and ritonavir: Absence of cross-toxicity with indinavir
    Vandercam, B
    Moreau, M
    Horsmans, C
    Gala, JL
    INFECTION, 1998, 26 (05) : 313 - 313
  • [20] Effect of indinavir on the intestinal exsorption of amprenavir, saquinavir and nelfinavir after intravenous administration in rats
    Gao, WH
    Kageyama, M
    Inoue, Y
    Tadano, J
    Fukumoto, K
    Fukushima, K
    Yamasaki, D
    Nishimura, A
    Yoshikawa, Y
    Shibata, N
    Takada, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (02) : 199 - 204
12345